Kevin Laliberte
Keine laufenden Positionen mehr
Karriereverlauf von Kevin Laliberte
Ehemalige bekannte Positionen von Kevin Laliberte
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AXSOME THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2021 | - |
| DOVA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2017 | - |
Ausbildung von Kevin Laliberte
| University of Michigan | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Kevin Laliberte
- Erfahrung
